| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |